 |
|
Role of Vitamin E in the Prevention of Cardiovascular Disease and Cancer—Reply
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
In Reply: Dr Punnam raises a question of whether different treatments for hypertension, hyperlipidemia, and diabetes received by participants in the Women’s Health Study may have confounded the findings. Participants in the Women’s Health Study were treated for these conditions by their personal physicians, not by the physicians in the Women’s Health Study. Thus it is possible that the treatments received may have differed among participants. However, the women were randomly assigned to the vitamin E and placebo groups. While randomization does not ensure the equal distribution of unmeasured confounders, with a study population of the size of the Women’s Health Study it is likely. As evidence of the success of the randomization procedure, the percentage of women with hypertension was similar in the 2 groups (25.6% in the vitamin E group vs 26.2% in the placebo group; P = .20), as was the percentage who had hyperlipidemia (29.3% vs 29.6%; . . . [Full Text of this Article]
I-Min Lee, MBBS, ScD
Ilee@rics.bwh.harvard.edu
Julie E. Buring, ScD
Division of Preventive Medicine
Department of Medicine
Brigham and Women's Hospital
Harvard Medical School
Boston, Mass
RELATED ARTICLES
Role of Vitamin E in the Prevention of Cardiovascular Disease and Cancer
Sujeeth R. Punnam
JAMA. 2005;294(19):2432.
EXTRACT
| FULL TEXT
Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer: The Women’s Health Study: A Randomized Controlled Trial
I-Min Lee, Nancy R. Cook, J. Michael Gaziano, David Gordon, Paul M Ridker, JoAnn E. Manson, Charles H. Hennekens, and Julie E. Buring
JAMA. 2005;294(1):56-65.
ABSTRACT
| FULL TEXT
|
